Physician profile
Sujoy Gill
NPI 1225246861
$295,521.26
in general payments reported to CMS, 2019-2025
45 companies · $107K in 2025
The $107K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $27K · 2021: $33K · 2022: $33K · 2023: $38K · 2024: $46K · 2025: $107K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $151K · Travel and Lodging: $17K · Food and Beverage: $12K · Education: $5,724 · Honoraria: $4,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150,950.11 |
| Travel and Lodging | $17,310.98 |
| Food and Beverage | $11,553.14 |
| Education | $5,723.94 |
| Honoraria | $4,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $158,510.48 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $48,482.16 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Grifols USA, LLC | $25,416.60 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Mylan Specialty L.P. | $25,196.68 | 2019-2024 | Yupelri, Yupelri |
| Janssen Pharmaceuticals, INC | $13,501.53 | 2020-2023 | Xarelto |
| Verona Pharma, INC. | $10,393.84 | 2025 | Ohtuvayre |
| Intuitive Surgical, INC. | $6,608.09 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $788.84 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Amgen INC. | $747.29 | 2021-2025 | Tezspire, Tavneos |
| Grifols Shared Services North America, INC. | $736.33 | 2023-2025 | Prolastin-C Liquid |
| Genentech USA, INC. | $690.11 | 2019-2025 | Xolair |
| Actelion Pharmaceuticals US, INC. | $496.32 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Genzyme Corporation | $466.51 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $418.23 | 2019-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $409.93 | 2020-2025 | Acthar |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $403.20 | 2023-2025 | Purified Cortrophin Gel |
| Insmed, INC. | $324.52 | 2019-2025 | Arikayce, Brinsupri |
| Merck Sharp & Dohme LLC | $268.08 | 2019-2025 | Winrevair |
| Novartis Pharmaceuticals Corporation | $262.92 | 2019-2024 | |
| United Therapeutics Corporation | $209.30 | 2021-2025 | Tyvaso, Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $205.19 | 2021-2025 | Glassia |
| Pfizer INC. | $113.79 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $111.14 | 2019-2025 | |
| Vifor Pharma, INC. | $109.61 | 2019-2025 | Zemaira |
| Baxter Healthcare | $93.49 | 2022-2024 | Hillrom - Monarch Airway Clearance System |
| Electromed, INC. | $93.24 | 2019-2025 | Smartvest |
| Paratek Pharmaceuticals, INC. | $64.72 | 2021 | |
| Sunovion Pharmaceuticals INC. | $41.10 | 2019 | |
| Viatris Specialty LLC | $39.98 | 2025 | Yupelri |
| Mallinckrodt Enterprises LLC | $35.47 | 2019 | |
| Covidien LP | $25.77 | 2019-2020 | |
| Atricure, INC. | $25.58 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Philips North America LLC | $25.12 | 2020 | |
| Azurity Pharmaceuticals, INC. | $24.38 | 2025 | Alvesco |
| 3b Medical, INC. | $22.97 | 2025 | Luna |
| Inogen, INC. | $21.95 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Biogen, INC. | $19.99 | 2025 | Spinraza |
| Axsome Therapeutics, INC. | $18.00 | 2023 | Sunosi |
| Covis Pharma Gmbh | $17.04 | 2022 | |
| Pharming Healthcare, INC. | $15.42 | 2023 | Ruconest |
| Gilead Sciences, INC. | $15.01 | 2019 | |
| Pulmonx Corporation | $14.09 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| La Jolla Pharmaceutical Company | $12.63 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.38 | 2021 | |
| Sandoz INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujoy Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.